In the time of the Covid-19 Pandemic, the same meta-data that protects us can be inadvertently manipulated to hurt us. In lower-middle-market healthcare transactions, we base our M&A health on actual data, not assumptions. The data is clear: our deal flow is thriving, and transactions continue to stay on track.